SANUWAVE Health, Inc. (SNWV) Fair Value 2026

SNWV · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.4 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-07-13, SANUWAVE Health, Inc. (SNWV) trades at $11.26, approximately 22% below CirclFi’s Bayesian DCF fair value of $14.41. QOC: 6.4/10. Value Trap Risk: 24/100 (SAFE). 12/13 models active.

Key Facts

Ticker
SNWV
Price
$11.26
Quality Score
6.4/10
Value Trap Risk
24/100
Models Active
12/13
Last Updated
Strength: First Chicago suggests +73.1% upside with 57% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($11.26)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$14.41 +28.0%
Earnings Power Value
Medium Conviction
$13.89 +23.4%
CUCE Ensemble
Low Conviction
$9.10 -19.2%
First Chicago
High Conviction
$19.49 +73.1%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is SANUWAVE Health, Inc. (SNWV) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, SANUWAVE Health, Inc.'s intrinsic value is estimated at a composite fair value of $9.27. Trading at $11.26, the stock is approaching fair value or slight overvaluation (implied return of -17.7%), as 8 of 12 models suggest limited further upside. Notably, First Chicago sees the most upside at +73.1% (fair value: $19.49), while Dynamic NAV is the most conservative at -91.6% ($0.95). The spread between these extremes — +164.6% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About SNWV?

12 of 13 models are currently active for SNWV. Of these, 4 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates SNWV's intrinsic value at $14.41, implying +28.0% upside from the current price. See which stocks rank higher →

How Does SNWV Rank in Surgical & Medical Instruments & Apparatus?

Among 111 Surgical & Medical Instruments & Apparatus stocks, SNWV ranks #60 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

SANUWAVE Health, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SNWV a Value Trap?

CirclFi's Value Trap algorithm assigns SNWV a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for SANUWAVE Health, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, SANUWAVE Health, Inc. scores 6.4 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +164.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SNWV valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SNWV's 12 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy SANUWAVE Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

Read investment analysis: DXCM · IRMD · PODD · RMD · WST

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About SANUWAVE Health, Inc.

What is SANUWAVE Health, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, SANUWAVE Health, Inc. (SNWV) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $14.41. The Quality of Company score is 6.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SNWV overvalued or undervalued right now?

At $11.26, 4 of 12 active models suggest SNWV may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits SANUWAVE Health, Inc.'s business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 6.4 mean for SNWV?

SANUWAVE Health, Inc.'s QOC of 6.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SNWV?

CirclFi analyzes SNWV with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is SNWV a value trap in 2026?

SANUWAVE Health, Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on SNWV.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access